Search results for "COMORBIDITY"

showing 10 items of 799 documents

Omalizumab and COVID-19 treatment: Could it help?

2020

Special Issue ArticlesCoronavirus disease 2019 (COVID-19)UrticariaPneumonia ViralMEDLINEOmalizumabDermatologyComorbidityOmalizumabBetacoronavirusCOVID‐19PandemicAnti-Allergic AgentsmedicineHumansPandemicsbiologybusiness.industryViral EpidemiologySARS-CoV-2COVID-19Special Issue ArticleGeneral Medicinemedicine.diseasebiology.organism_classificationVirologyComorbidityPneumoniaTherapybusinessCoronavirus InfectionsBetacoronavirusmedicine.drugDermatologic therapy
researchProduct

Psoriatic arthritis and COVID ‐19 pandemic: Consequences in medical treatment?

2020

The COVID‐19 pandemic has a strong negative impact on human society world‐wide. Patients with immune‐mediated disease may be prone to an increased risk of infection and/ or more severe course. We review the available data for patients with psoriatic arthritis (PSA) and systemic treatments. Current treatment options are summarized. Based upon the experience with COVID‐19 the following problems are addressed: (a) Can systemic treatment reduce comorbidities of PsA that are also comorbidities for COVID‐19? Does systemic medical treatment pose an increased risk of infection with SARS‐CoV‐2? Does systemic drug therapy have an impact on the risk of pulmonary fibrosis ‐ a factor with strong negativ…

Special Issue Articlesmedicine.medical_specialtyDiseaseComorbidityDermatologyPlacebo030207 dermatology & venereal diseases03 medical and health sciencesPsoriatic arthritisPsoriatic arthritis; systemic medical treatment0302 clinical medicinePharmacotherapyCOVID‐19Internal medicinePandemicmedicineHumansJanus Kinase InhibitorsbiologicsBiological Productsbusiness.industrySARS-CoV-2Tumor Necrosis Factor-alphaArthritis PsoriaticInterleukinSpecial Issue ArticleCOVID-19General Medicinemedicine.diseaseComorbiditysmall molecules030220 oncology & carcinogenesisAirwaybusinessDermatologic Therapy
researchProduct

The German COPD cohort COSYCONET: Aims, methods and descriptive analysis of the study population at baseline

2016

Abstract Background The German COPD cohort study COSYCONET (" CO PD and SY stemic consequences- CO morbidities NET work") investigates the interaction of lung disease, comorbidities and systemic inflammation. Recruitment took place from 2010 to 2013 in 31 study centers. In addition to the baseline visit, follow-up visits are scheduled at 6, 18, 36 and 54 months after baseline. The study also comprises a biobank, image bank, and includes health economic data. Here we describe the study design of COSYCONET and present baseline data of our COPD cohort. Methods Inclusion criteria were broad in order to cover a wide range of patterns of the disease. In each visit, patients undergo a large panel …

SpirometryAdultMalePulmonary and Respiratory Medicinemedicine.medical_specialtyComorbiditySeverity of Illness IndexCohort Studies03 medical and health sciencesPulmonary Disease Chronic Obstructive0302 clinical medicineRisk FactorsInternal medicineGermanySeverity of illnessMedicineHumansCOPD030212 general & internal medicineProspective StudiesProspective cohort studyAgedAged 80 and overCOPDmedicine.diagnostic_testSystemic inflammationbusiness.industrySmokingCohortStudy designMiddle Agedmedicine.diseaseComorbiditySystemic Inflammatory Response SyndromeObservational Studies as Topic030228 respiratory systemCohortPhysical therapyDisease ProgressionPopulation studyFemaleCohort ; Comorbidity ; Copd ; Study Design ; Systemic InflammationbusinessCohort studyFollow-Up StudiesRespiratory Medicine
researchProduct

Comorbidities and quality of life in obstructed adults in a primary care setting

2016

Introduction: Comorbidities are known to impair Quality of Life (QoL)in patients with chronic obstruction pulmonary disease. A poor QoL is associated with higher dyspnoea perception. How comorbidities influence QoL in these patients is limited and needs clarification. Aim: To study the role of dyspnoea perception in the relationship between comorbidities number and QoL in obstructed and not obstructed adults in a primary care setting. Methods: Seventeen general practitioners participated to the study: 566 adults, attending the Practitioner9s study for any reason, performed spirometry and fulfilled a respiratory questionnaire between January and June 2014. 259 adults (148 M, aged 40-88) acce…

Spirometrymedicine.medical_specialtyQuality of life. Spirometry Comorbiditiesmedicine.diagnostic_testbusiness.industrySignificant differencePrimary caremedicine.diseaseComorbidityMental healthhumanitiesFEV1/FVC ratioQuality of lifemedicineGlobal healthPhysical therapybusiness
researchProduct

2016

Abstract Background: The association of attention-deficit/hyperactivity disorder (ADHD) and tic disorder (TD) is frequent and clinically important. Very few and inconclusive attempts have been made to clarify if and how the combination of ADHD+TD runs in families. Aim: To determine the first time in a large-scale ADHD sample whether ADHD+TD increases the risk of ADHD+TD in siblings and, also the first time, if this is independent of their psychopathological vulnerability in general. Methods: The study is based on the International Multicenter ADHD Genetics (IMAGE) study. The present sub-sample of 2815 individuals included ADHD-index patients with co-existing TD (ADHD+TD, n=262) and without …

Tic disordermedicine.medical_specialty05 social sciencesmedicine.diseasebehavioral disciplines and activitiesComorbidityTourette syndrome3. Good health03 medical and health sciences0302 clinical medicineRating scalemental disordersmedicineCriterion validityAttention deficit hyperactivity disorder0501 psychology and cognitive sciencesSiblingPsychologyPsychiatry030217 neurology & neurosurgeryGeneral Psychology050104 developmental & child psychologyClinical psychologyPsychopathologyFrontiers in Psychology
researchProduct

Early cardiovascular events in women with a history of gestational diabetes mellitus

2016

International audience; Background: The effect of gestational diabetes mellitus (GDM) on cardiovascular diseases (CVD) is not assessed within the first 10 years postpartum, regardless of subsequent diabetes. The aim of this study was to determine the risk of CVD events related to GDM within 7 years of postpartum.Methods: This nationwide population-based study of deliveries in 2007 and 2008 with a follow-up of 7 years was based on data from the French medico-administrative database. Two groups were formed: women with a history of GDM and women without GDM or previous diabetes. CVD included angina pectoris, myocardial infarction, stroke, heart bypass surgery, coronary angioplasty, carotid end…

Time FactorsDatabases Factualendocrine system diseasesEndocrinology Diabetes and MetabolismComorbidity030204 cardiovascular system & hematologyVascular dysfunctionAnginaDiabetes mellitus0302 clinical medicineRisk FactorsPregnancyOdds RatioPrevalenceGestational diabetesOriginal InvestigationCoronary diseaseeducation.field_of_study[ SDV.MHEP.CSC ] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system[ SDV.MHEP.EM ] Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismMetaanalysis[SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolismCardiovascular disease3. Good healthGestational diabetesCardiovascular DiseasesHypertensionFemaleFranceCardiology and Cardiovascular MedicineAdultmedicine.medical_specialtyPopulationAdministrative data030209 endocrinology & metabolismRisk AssessmentYoung Adult03 medical and health sciences[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemInternal medicineDiabetes mellitusmedicineHumansHeart bypasscardiovascular diseasesRisk factoreducationbusiness.industryOdds ratiomedicine.diseaseComorbidityDiabetes GestationalLogistic ModelsCase-Control StudiesbusinessCardiovascular Diabetology
researchProduct

Interventions aimed at reducing obsessive-compulsive symptoms in people with autism spectrum disorder: A review

2021

espanolEl trastorno del espectro autista (TEA) es un trastorno del neurodesarrollo caracterizado por deficits en la comunicacion e interaccion social y por comportamientos restrictivos y repetitivos. Presenta una elevada comorbilidad con otros trastornos, de hasta un 37% con el trastorno obsesivo compulsivo (TOC) en pacientes jovenes. El TOC se caracteriza por pensamientos e ideas recurrentes que llevan a la persona a realizar acciones compulsivas para disminuir el nivel de ansiedad que estos pensamientos le generan. Este trabajo presenta una revision de los metodos psicologicos de intervencion utilizados, asi como de la efectividad de los mismos, en la reduccion de los sintomas del TOC com…

Trastornos psiquiátricosPsychotherapistmedicine.medical_treatmentHastaPersonamedicine.diseaseComorbidityIntervenciónRepetitive behaviorCognitive behavioral therapyTrastornos del espectro autistaTerapiamedicineJuventudAnxietySpectrum disorderTrastornos psicológicosSíntomasmedicine.symptomPsychologyLiteratura científicaDiagnóstico dualEscritos de Psicología - Psychological Writings
researchProduct

Asymptomatic Carotid Lesion as a Marker of Future Cerebrovascular and Cardiovascular Events

2003

Tunica mediamedicine.medical_specialtyAngiotensin-Converting Enzyme InhibitorsComorbidityAsymptomaticText miningRisk FactorsCarotid lesionmedicineHumansCarotid StenosisRandomized Controlled Trials as TopicEndarterectomy Carotidbusiness.industryGeneral MedicineStrokeCarotid Arteriesmedicine.anatomical_structureCardiovascular DiseasesHypertensionSurgeryThickeningRadiologyHydroxymethylglutaryl-CoA Reductase Inhibitorsmedicine.symptomTunica IntimabusinessPlatelet Aggregation InhibitorsActa Chirurgica Belgica
researchProduct

Predictors of early dropout in treatment for gambling disorder: The role of personality disorders and clinical syndromes

2017

Several treatment options for gambling disorder (GD) have been tested in recent years; however dropout levels still remain high. This study aims to evaluate whether the presence of psychiatric comorbidities predicts treatment outcome according to Millon's evolutionary theory, following a six-month therapy for GD. The role of severity, duration of the disorder, typology of gambling (mainly online or offline) and pharmacological treatment were also analysed. The recruitment included 194 pathological gamblers (PGs) to be compared with 78 healthy controls (HCs). Psychological assessment included the South Oaks Gambling Screen and the Millon Clinical Multiaxial Inventory-III. The "treatment fail…

TypologyAdultMalemedicine.medical_specialtyPatient DropoutsAdolescentSubstance-Related Disorders030508 substance abuseComorbidityPersonality DisordersStress Disorders Post-Traumatic03 medical and health sciencesYoung Adult0302 clinical medicineSettore M-PSI/08 - Psicologia ClinicamedicineSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.HumansPsychological testingTreatment FailurePsychiatryPathologicalSettore MED/25 - PsichiatriaBiological PsychiatryDropout (neural networks)AgedAntisocial personality disorderAntisocial Personality DisorderSyndromeMiddle Agedmedicine.diseasePersonality disorders030227 psychiatryPsychotherapyPsychiatry and Mental healthPassive-Aggressive Personality DisorderCase-Control StudiesGamblingGambling disorderFemale0305 other medical sciencePsychologyGambling disorder Dropout Treatment outcome Personality disorders Clinical syndromes Psychiatric disorders Disordered gambling Pathological gamblingClinical psychology
researchProduct

Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation.

2018

Nonalcoholic fatty liver disease (NAFLD) affects 25% of the global adult population with a range of 13.5% in Africa and 31.8% in the Middle East. Nonalcoholic fatty liver disease is closely associated with a constellation of metabolic comorbidities which include: obesity, type 2 diabetes mellitus, hypertension, and hypercholesteremia. In fact, the increasing number of metabolic comorbidities not only increases the prevalence of NAFLD but also places patients at higher risk for progressive liver disease. As such, NAFLD is presently among the top etiologies for hepatocellular carcinoma and an indication for liver transplantation (LT) in the United States. Therefore, the following recommendati…

United StateLiver Cirrhosismedicine.medical_specialtyCarcinoma HepatocellularTissue and Organ ProcurementWaiting ListsLiver Cirrhosimedicine.medical_treatmentComorbidity030230 surgeryLiver transplantationdigestive system03 medical and health sciencesLiver disease0302 clinical medicineNon-alcoholic Fatty Liver DiseaseRisk FactorsInternal medicineEpidemiologyNonalcoholic fatty liver diseasePrevalenceMedicineHumansMetabolic SyndromeTransplantationbusiness.industryRisk FactorIncidencePatient SelectionLiver Neoplasmsnutritional and metabolic diseasesType 2 Diabetes Mellitusmedicine.diseaseComorbidityObesitydigestive system diseasesUnited StatesLiver TransplantationLiver NeoplasmWaiting ListDisease Progression030211 gastroenterology & hepatologyMetabolic syndromebusinessHumanTransplantation
researchProduct